A new study published in The researchers found that people with type 2 diabetes taking GLP-1 drugs are more likely to experience alopecia, particularly non-scarring alopecia
Factors That Influence Your 3-Month Results The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
A personalized approach to genetic context, surgical history, and medication selection increases the likelihood of safe, sustainable weight loss after gallbladder removal
Many of these supps are under-researched and don't have a large body of proof suggesting they'll make a GLP-1-level difference
The fundamental monitoring approach remains the same, though your provider may pay closer attention to gastrointestinal tolerability and nutritional status